Lindbrook Capital’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.59K | Buy |
254
+99
| +64% | +$621 | ﹤0.01% | 2347 |
|
|
2024
Q4 | $1.26K | Buy |
+155
| New | +$1.26K | ﹤0.01% | 2439 |
|
|
2023
Q4 | – | Sell |
-132
| Closed | -$1.37K | – | 2803 |
|
|
2023
Q3 | $1.37K | Hold |
132
| – | – | ﹤0.01% | 2259 |
|
|
2023
Q2 | $1.89K | Buy |
+132
| New | +$1.89K | ﹤0.01% | 2164 |
|
|
2023
Q1 | – | Sell |
-159
| Closed | -$1.78K | – | 2895 |
|
|
2022
Q4 | $1.78K | Sell |
159
-14
| -8% | -$157 | ﹤0.01% | 2277 |
|
|
2022
Q3 | $2K | Buy |
173
+127
| +276% | +$1.47K | ﹤0.01% | 2114 |
|
|
2022
Q2 | $0 | Sell |
46
-91
| -66% | – | ﹤0.01% | 2718 |
|
|
2022
Q1 | $2K | Buy |
+137
| New | +$2K | ﹤0.01% | 2052 |
|